Medpace Holdings, Inc.
MEDP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2,109,054 | $1,885,842 | $1,459,996 | $1,142,377 |
| % Growth | 11.8% | 29.2% | 27.8% | – |
| Cost of Goods Sold | $1,452,749 | $1,361,337 | $1,027,558 | $814,222 |
| Gross Profit | $656,305 | $524,505 | $432,438 | $328,155 |
| % Margin | 31.1% | 27.8% | 29.6% | 28.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $178,684 | $0 | $0 | $0 |
| SG&A Expenses | $180,184 | $161,352 | $131,400 | $108,421 |
| Sales & Mktg Exp. | $1,500 | $0 | $0 | $0 |
| Other Operating Expenses | $29,251 | $26,328 | $22,341 | $21,119 |
| Operating Expenses | $209,435 | $187,680 | $153,741 | $129,540 |
| Operating Income | $446,870 | $336,825 | $278,697 | $198,615 |
| % Margin | 21.2% | 17.9% | 19.1% | 17.4% |
| Other Income/Exp. Net | $29,052 | -$1,143 | $4,163 | $3,237 |
| Pre-Tax Income | $475,922 | $335,682 | $282,860 | $201,852 |
| Tax Expense | $71,536 | $52,872 | $37,492 | $20,004 |
| Net Income | $404,386 | $282,810 | $245,368 | $181,848 |
| % Margin | 19.2% | 15% | 16.8% | 15.9% |
| EPS | 13.06 | 9.2 | 7.57 | 5.06 |
| % Growth | 42% | 21.5% | 49.6% | – |
| EPS Diluted | 12.63 | 8.88 | 7.28 | 4.81 |
| Weighted Avg Shares Out | 30,957 | 30,722 | 32,388 | 35,862 |
| Weighted Avg Shares Out Dil | 32,014 | 31,841 | 33,671 | 37,697 |
| Supplemental Information | – | – | – | – |
| Interest Income | $24,996 | $0 | $0 | $0 |
| Interest Expense | $0 | $488 | $2,905 | $105 |
| Depreciation & Amortization | $29,251 | $26,328 | $22,341 | $21,119 |
| EBITDA | $476,121 | $363,153 | $301,038 | $219,734 |
| % Margin | 22.6% | 19.3% | 20.6% | 19.2% |